Juvenile psoriatic arthritis
Also known as: Psoriatic Arthritis, Juvenile / Oligoarthritis, Juvenile / Juvenile psoriatic arthritis (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB09029 | Secukinumab | An immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB09029 | Secukinumab | Interleukin-17A | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB05679 | Ustekinumab | 1 | Completed | 1 |
DB00051 | Adalimumab | 3 | Active Not Recruiting | 1 |
DB00051 | Adalimumab | 3 | Recruiting | 1 |
DB05676 | Apremilast | 3 | Recruiting | 1 |
DB02325 | Isopropyl alcohol | 3 | Recruiting | 1 |
DB11569 | Ixekizumab | 3 | Active Not Recruiting | 1 |
DB14762 | Risankizumab | 3 | Recruiting | 1 |
DB09029 | Secukinumab | 3 | Active Not Recruiting | 1 |
DB09029 | Secukinumab | 3 | Completed | 1 |
DB08895 | Tofacitinib | Not Available | Not Yet Recruiting | 1 |